Budesonidum limits survival ovarian cancer cells in vitro
Background Ovarian cancer is one of the most common and worst gynecological cancers. According to statistics, ovarian cancer ranks fifth among deaths from all cancer deaths in the female population in Poland. The low effectiveness of treatment is the reason for the constant search for new therapeuti...
Saved in:
Main Authors: | Klaudia Nyga (Author), Zuzanna Perkowska (Author), Maciej Małecki (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ointments, creams and gels in experimental and clinical oncology
by: Dorota Sylwia Sawczuk, et al.
Published: (2023) -
Carboplatin-induced gene expression changes <it>in vitro</it> are prognostic of survival in epithelial ovarian cancer
by: Cannistra Stephen A, et al.
Published: (2008) -
Aspirin use correlates with survival in women with clear cell ovarian cancer
by: Alyssa M. Wield, et al.
Published: (2018) -
Progesterone reduces cell survival in primary cultures of endometrioid ovarian cancer
by: Enrique Pedernera, et al.
Published: (2019) -
Survival Outcomes Between Clear Cell and Non-Clear Cell Epithelial Ovarian Cancer
by: Wasanai Jermsirisakpong, et al.
Published: (2013)